Telomir Pharmaceuticals (TELO) Earnings Date, Estimates & Call Transcripts $3.91 -0.27 (-6.46%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.94 +0.03 (+0.90%) As of 02/21/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Telomir Pharmaceuticals Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 12EstimatedActual EPS (Feb. 4) -$0.10 Missed By -$0.05 Consensus EPS (Feb. 4) -$0.05 Telomir Pharmaceuticals posted Q4 2024 earnings on February 4, 2025, reporting an EPS of -$0.10, which missed analysts' consensus estimates of -$0.05 by $0.05. With a trailing EPS of -$0.58, Telomir Pharmaceuticals' earnings are expected to grow next year, from ($0.40) to ($0.36) per share. TELO Upcoming EarningsTelomir Pharmaceuticals' next earnings date is estimated for Monday, May 12, 2025, based off prior year's reporting schedules. Get Telomir Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Telomir Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTELO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TELO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Telomir Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.10-$0.10-$0.10Q2 20251-$0.10-$0.10-$0.10Q3 20251-$0.10-$0.10-$0.10Q4 20251-$0.10-$0.10-$0.10FY 20254-$0.40-$0.40-$0.40Q1 20261-$0.09-$0.09-$0.09Q2 20261-$0.10-$0.10-$0.10Q3 20261-$0.08-$0.08-$0.08Q4 20261-$0.09-$0.09-$0.09FY 20264($0.36)($0.36)($0.36) Telomir Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)-------2/4/2025Q4 2024-$0.05-$0.10 -$0.05-$0.10--11/12/2024---$0.20 -$0.20-$0.20--8/13/2024Q2 2024--$0.05 -$0.05-$0.05--5/13/2024Q1 2024--$0.23 -$0.23-$0.23-- Telomir Pharmaceuticals Earnings - Frequently Asked Questions When is Telomir Pharmaceuticals's earnings date? Telomir Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on TELO's earnings history. Did Telomir Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Telomir Pharmaceuticals (NASDAQ:TELO) missed the analysts' consensus estimate of ($0.05) by $0.05 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. TELO's actual earnings. How much profit does Telomir Pharmaceuticals generate each year? Telomir Pharmaceuticals (NASDAQ:TELO) has a recorded net income of -$16.53 million. TELO has generated -$0.58 earnings per share over the last four quarters. What is Telomir Pharmaceuticals's EPS forecast for next year? Telomir Pharmaceuticals's earnings are expected to grow from ($0.40) per share to ($0.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies MLYS Earnings Results TRDA Earnings Results RNAC Earnings Results HUMA Earnings Results ARCT Earnings Results SNDL Earnings Results KALV Earnings Results PROK Earnings Results PGEN Earnings Results ORGO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? This page (NASDAQ:TELO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
